复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
复星医药(600196) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入1,015,725.534,139,953.963,070,011.912,139,519.261,087,072.08
营业收入1,015,725.534,139,953.963,070,011.912,139,519.261,087,072.08
二、营业总成本952,243.354,128,407.693,028,427.922,063,204.191,009,828.44
营业成本507,770.642,159,530.881,577,952.121,069,852.05529,479.36
营业税金及附加9,244.1727,125.5419,796.2113,757.306,702.14
销售费用224,023.09971,223.74722,668.19507,129.56251,524.87
管理费用100,226.91437,490.72316,893.34204,500.7699,109.25
财务费用28,021.8298,432.3475,607.8854,536.6526,125.61
研发费用82,956.72434,604.47315,510.17213,427.8796,887.22
资产减值损失----------
公允价值变动收益-2,013.73-42,737.9680,633.6438,737.39-14,760.61
投资收益33,555.80350,199.26218,241.73147,338.0776,590.45
其中:对联营企业和合营企业的投资收益33,032.50218,484.87149,592.24102,226.3436,634.49
汇兑收益----------
三、营业利润102,136.41330,750.79334,219.78268,261.08142,713.93
加:营业外收入931.415,712.404,959.072,420.59562.37
减:营业外支出1,225.4310,006.409,933.205,134.674,799.89
其中:非流动资产处置损失----------
四、利润总额101,842.39326,456.79329,245.65265,547.00138,476.40
减:所得税费用23,220.2736,950.4563,864.7061,024.4727,050.99
五、净利润78,622.12289,506.34265,380.95204,522.53111,425.41
归属于母公司所有者的净利润60,973.36238,626.58228,306.59177,747.1998,697.17
少数股东损益17,648.7550,879.7637,074.3626,775.3412,728.24
六、每股收益
基本每股收益(元/股)0.23000.89000.86000.67000.3700
稀释每股收益(元/股)0.23000.89000.85000.67000.3700
七、其他综合收益9,115.423,185.7238,304.7247,560.58-18,348.65
八、综合收益总额87,737.54292,692.06303,685.68252,083.1193,076.76
归属于母公司所有者的综合收益总额68,523.31235,082.38250,227.09203,629.4883,437.13
归属于少数股东的综合收益总额19,214.2357,609.6853,458.5948,453.639,639.64
下载全部历史数据到excel中 返回页顶